Remodeling the Tumor Immune Environment in Breast Cancer via Bortezomib-based Combination Therapy
International Journal of Biological Sciences · 2025
DOI: 10.7150/ijbs.122366 ↗Kurz gefasst
Kommentar in der Zeitschrift International Journal of Biological Sciences, 2025. Verfasst von Shaojuan Huang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, Faculty of Health Sciences, University of Macau, Taipa, Macau SAR, China. Hauptthemen laut MEDLINE: Breast Neoplasms, Boronic Acids, Antineoplastic Agents, Pyrazines. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Sciences, Faculty of Health Sciences, University of Macau, Taipa, Macau SAR, China.
- Cancer Centre, Faculty of Health Sciences, University of Macau, Taipa, Macau SAR, China.
- MOE Frontier Science Centre for Precision Oncology, University of Macau, Taipa, Macau SAR, China.
Zitieren
APA
Huang, S., & Chen, Q. (2025). Remodeling the Tumor Immune Environment in Breast Cancer via Bortezomib-based Combination Therapy. International Journal of Biological Sciences. https://doi.org/10.7150/ijbs.122366
Vancouver
Huang S, Chen Q. Remodeling the Tumor Immune Environment in Breast Cancer via Bortezomib-based Combination Therapy. International Journal of Biological Sciences. 2025. doi:10.7150/ijbs.122366
BibTeX
@article{Huang2025,
author = {Huang, Shaojuan and Chen, Qiang},
title = {Remodeling the Tumor Immune Environment in Breast Cancer via Bortezomib-based Combination Therapy},
journal = {International Journal of Biological Sciences},
year = {2025},
doi = {10.7150/ijbs.122366}
}
EUVIMED